A Clinical Research of Siddha Medicine in the treatment of Sooli Kanam (Childhood Asthma)
Phase 3
- Conditions
- Health Condition 1: null- Soolikanam (Childhood Asthma)
- Registration Number
- CTRI/2017/05/008540
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1.Age : 7 â?? 12 years
2.Cough
3.Wheezing
4.Tightness of chest
5.Shortness of breath
6.Abdominal bloating
7.Loss of appetite
Exclusion Criteria
1.Children below 7 years and above 12 years
2.Haemoptysis
3.Pneumonia
4.Congenital heart disease
5.Status Asthmaticus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of the trail drug is measured by Peak Expiratory Flow MeterTimepoint: Before treatment (0th day) and After treatment (40th day)
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the following parameters before and after the treatment <br/ ><br>1.Improve clinical symptoms <br/ ><br>2.Reduction in AEC and ESRTimepoint: Before treatment and After treatment